Aditxt, Inc. (NASDAQ:ADTX) Short Interest Down 45.2% in December

Aditxt, Inc. (NASDAQ:ADTX) was the recipient of a significant decrease in short interest in December. As of December 15th, there was short interest totalling 99,100 shares, a decrease of 45.2% from the November 30th total of 180,800 shares. Based on an average daily volume of 3,270,000 shares, the short-interest ratio is currently 0.0 days. Approximately 0.7% of the company’s stock are sold short.

Insider Buying and Selling

In related news, major shareholder Financial Lp Hrt sold 25,534 shares of the company’s stock in a transaction on Wednesday, October 16th. The shares were sold at an average price of $1.17, for a total value of $29,874.78. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 1.72% of the stock is currently owned by corporate insiders.

Aditxt Stock Down 2.3 %

Aditxt stock traded down $0.00 on Friday, reaching $0.19. 6,484,513 shares of the stock were exchanged, compared to its average volume of 938,863. Aditxt has a twelve month low of $0.18 and a twelve month high of $338.80. The firm has a fifty day moving average price of $0.43 and a two-hundred day moving average price of $24.98.

Aditxt Company Profile

Aditxt, Inc, a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues.